These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35020842)

  • 21. Aberrant expression of the innate restriction factor bone marrow stromal antigen-2 in primary Sjögren's syndrome.
    Chen C; Shi H; Wang B; Cao N; Yu C; Zheng L
    J Craniomaxillofac Surg; 2018 Nov; 46(11):1899-1904. PubMed ID: 30249485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteomics of saliva, plasma, and salivary gland tissue in Sjögren's syndrome and non-Sjögren patients identify novel biomarker candidates.
    Sembler-Møller ML; Belstrøm D; Locht H; Pedersen AML
    J Proteomics; 2020 Aug; 225():103877. PubMed ID: 32540407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CMTM6 and CMTM4 as two novel regulators of PD-L1 modulate the tumor microenvironment.
    Zhang T; Yu H; Dai X; Zhang X
    Front Immunol; 2022; 13():971428. PubMed ID: 35958549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B7-H3 participates in human salivary gland epithelial cells apoptosis through NF-κB pathway in primary Sjögren's syndrome.
    Li P; Yang Y; Jin Y; Zhao R; Dong C; Zheng W; Zhang T; Li J; Gu Z
    J Transl Med; 2019 Aug; 17(1):268. PubMed ID: 31412888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CMTM6-Deficient Monocytes in ANCA-Associated Vasculitis Fail to Present the Immune Checkpoint PD-L1.
    Zeisbrich M; Chevalier N; Sehnert B; Rizzi M; Venhoff N; Thiel J; Voll RE
    Front Immunol; 2021; 12():673912. PubMed ID: 34108971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High membrane expression of CMTM6 in hepatocellular carcinoma is associated with tumor recurrence.
    Muranushi R; Araki K; Yokobori T; Chingunjav B; Hoshino K; Dolgormaa G; Hagiwara K; Yamanaka T; Ishii N; Tsukagoshi M; Igarashi T; Watanabe A; Kubo N; Harimoto N; Shimoda Y; Sano R; Oyama T; Saeki H; Shirabe K
    Cancer Sci; 2021 Aug; 112(8):3314-3323. PubMed ID: 34080242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disease activity and damage in patients with primary Sjogren's syndrome: Prognostic value of salivary gland ultrasonography.
    Milic V; Colic J; Cirkovic A; Stanojlovic S; Damjanov N
    PLoS One; 2019; 14(12):e0226498. PubMed ID: 31891590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of Toll-like receptor 7 signaling in labial salivary glands of primary Sjögren's syndrome patients.
    Shimizu T; Nakamura H; Takatani A; Umeda M; Horai Y; Kurushima S; Michitsuji T; Nakashima Y; Kawakami A
    Clin Exp Immunol; 2019 Apr; 196(1):39-51. PubMed ID: 30446998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome.
    Lavie F; Miceli-Richard C; Quillard J; Roux S; Leclerc P; Mariette X
    J Pathol; 2004 Apr; 202(4):496-502. PubMed ID: 15095277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of CMTM6 and CMTM4 as PD-L1 protein regulators.
    Mezzadra R; Sun C; Jae LT; Gomez-Eerland R; de Vries E; Wu W; Logtenberg MEW; Slagter M; Rozeman EA; Hofland I; Broeks A; Horlings HM; Wessels LFA; Blank CU; Xiao Y; Heck AJR; Borst J; Brummelkamp TR; Schumacher TNM
    Nature; 2017 Sep; 549(7670):106-110. PubMed ID: 28813410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CMTM6 is positively correlated with PD-L1 expression and immune cells infiltration in lung squamous carcinoma.
    Shang X; Li J; Wang H; Li Z; Lin J; Chen D; Wang H
    Int Immunopharmacol; 2020 Nov; 88():106864. PubMed ID: 32866782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ductal cells of minor salivary glands in Sjögren's syndrome express LINE-1 ORF2p and APOBEC3B.
    Kalogirou EM; Piperi EP; Tosios KI; Tsiambas E; Fanourakis G; Sklavounou A
    J Oral Pathol Med; 2018 Feb; 47(2):179-185. PubMed ID: 29057505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative Assessment of CMTM6 in the Tumor Microenvironment and Association with Response to PD-1 Pathway Blockade in Advanced-Stage Non-Small Cell Lung Cancer.
    Zugazagoitia J; Liu Y; Toki M; McGuire J; Ahmed FS; Henick BS; Gupta R; Gettinger SN; Herbst RS; Schalper KA; Rimm DL
    J Thorac Oncol; 2019 Dec; 14(12):2084-2096. PubMed ID: 31605795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression of osteopontin in labial glands of patients with primary Sjögren's syndrome].
    Wang YH; Zhao MS; Zhao Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):236-9. PubMed ID: 22516995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathologic and prognostic significance of CMTM6 and PD-L1 expression in cervical squamous cell carcinoma.
    Ma H; Shi S; Ma Z; Sun J; Liu X; Niu S; Liu H; Zhang Z
    Int J Clin Exp Pathol; 2023; 16(12):368-377. PubMed ID: 38188349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Co-expression of CMTM6 and PD-L1: a novel prognostic indicator of gastric cancer.
    Zhang C; Zhao S; Wang X
    Cancer Cell Int; 2021 Jan; 21(1):78. PubMed ID: 33509216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased CMTM6 can predict the clinical response to PD-1 inhibitors in non-small cell lung cancer patients.
    Koh YW; Han JH; Haam S; Jung J; Lee HW
    Oncoimmunology; 2019; 8(10):e1629261. PubMed ID: 31646074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunophenotypes and clinical features of lymphocytes in the labial gland of primary Sjogren's syndrome patients.
    Sun W; Zhang N; Zhang Y; Shao Z; Gong L; Wei W
    J Clin Lab Anal; 2018 Nov; 32(9):e22585. PubMed ID: 29923220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression of CD4+ CD25+ regulatory T cells in peripheral blood and salivary gland of patients with primary Sjögren's syndrome].
    Li XM; Li XP; Qian L; Wang GS; Zhang H; Zhei ZM; Li Q; Chen K; Wang XQ; Wang YP
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1034-6. PubMed ID: 17672966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study.
    Carubbi F; Cipriani P; Marrelli A; Benedetto P; Ruscitti P; Berardicurti O; Pantano I; Liakouli V; Alvaro S; Alunno A; Manzo A; Ciccia F; Gerli R; Triolo G; Giacomelli R
    Arthritis Res Ther; 2013 Oct; 15(5):R172. PubMed ID: 24286296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.